Lewis Williams
Director/Board Member at PROTAGONIST THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2024
Lewis Williams active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 08/06/2017 | - |
| Independent Dir/Board Member | 08/06/2017 | - | |
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA. | Chief Executive Officer | 01/02/2019 | - |
| Chairman | 01/02/2019 | - | |
| Founder | 01/08/2018 | - | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | - | - |
Career history of Lewis Williams
Former positions of Lewis Williams
| Companies | Position | Start | End |
|---|---|---|---|
| ARCELLX, INC. | Director/Board Member | 01/08/2019 | 16/05/2022 |
| Independent Dir/Board Member | 01/08/2019 | 16/05/2022 | |
| NEUROGENE INC. | Director/Board Member | 09/08/2019 | 02/03/2022 |
| Independent Dir/Board Member | 09/08/2019 | 02/03/2022 | |
| FIVE PRIME THERAPEUTICS, INC. | Director/Board Member | 01/01/2019 | 31/12/2019 |
| Chief Executive Officer | 01/08/2011 | 02/01/2018 | |
| Chairman | 15/03/2016 | 01/01/2019 | |
| Founder | 01/12/2001 | 31/12/2019 | |
| President | 16/09/2011 | 02/01/2018 | |
| The University of California, San Francisco | Corporate Officer/Principal | 01/08/1984 | 01/08/2013 |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Director/Board Member | 23/10/2009 | 30/06/2011 |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Director/Board Member | 01/06/1989 | 11/06/2007 |
| Founder | 01/06/1989 | 11/06/2007 | |
| ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░ ░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░ ░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░ ░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Lewis Williams
| Duke University | Doctorate Degree |
| Rice University | Undergraduate Degree |
Statistics
International
| United States | 23 |
| Canada | 2 |
Operational
| Director/Board Member | 13 |
| President | 4 |
| Corporate Officer/Principal | 4 |
Sectoral
| Health Technology | 13 |
| Consumer Services | 6 |
| Technology Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| ARCELLX, INC. | Health Technology |
| Private companies | 16 |
|---|---|
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Medsphere Systems Corp.
 Medsphere Systems Corp. Information Technology ServicesTechnology Services Medsphere Systems Corp. engages in the provision of healthcare information technology platform solutions and services. It offers hospital EHR, rev cycle management, physician practice EHR, supply chain MGMT, weelsoft EDIS, and phoenix IT services.. The company was founded by Steven G. Shreeve and Scott Shreeve in 2002 and is headquartered in Carlsbad, CA. | Technology Services |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
AmerisourceBergen Technology Group
 AmerisourceBergen Technology Group Pharmaceuticals: MajorHealth Technology AmerisourceBergen Technology Group (ABTG) takes great pride in the solutions they deliver to healthcare and pharmacy services providers every day. From small community pharmacies dispensing a few dozen prescriptions per shift to multi-facility health systems supporting thousands of lives, ABTG has technology solutions that will help increase patient safety, streamline medication management processes and control costs. The ultimate goal is to provide their business partners with safer and smarter ways to care for their patients, customers and communities. | Health Technology |
Bridge Medical, Inc.
 Bridge Medical, Inc. Packaged SoftwareTechnology Services Bridge Medical, Inc. provided patient safety software and services to the healthcare industry. It used bar-code technology in healthcare to reduce medication and other clinical errors. The company was founded in 1996 and was headquartered in Solana Beach, CA. | Technology Services |
Chiron Technologies, Inc.
 Chiron Technologies, Inc. Computer Processing HardwareElectronic Technology Chiron Technologies, Inc. focuses on electronic computers. The company is headquartered in Colts Neck, NJ. | Electronic Technology |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
Juvaris BioTherapeutics, Inc.
 Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Health Technology |
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Health Technology |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA. | Health Technology |
Cardiovascular Research Institute
 Cardiovascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Cardiovascular Research Institute operates a cardiovascular research institute. The American company was founded by Alison Schecter. | Commercial Services |
- Stock Market
- Insiders
- Lewis Williams
- Experience
